Streetbeat News

Price Targets

IMAX

Rosenblatt analyst Steve Frankel maintains a 'Buy' rating on Imax (NYSE:IMAX) and raises the price target from $27 to $30.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 11:07 am

SBRA

Berenberg analyst Tao Qiu has initiated coverage on Sabra Health Care REIT (NASDAQ:SBRA) with a Hold rating and a price target of $13.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:44 am

CTRE

Berenberg analyst Tao Qiu has initiated coverage on CareTrust REIT (NYSE:CTRE) with a Buy rating and a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:43 am

RTX

B of A Securities analyst Ronald Epstein has downgraded RTX (NYSE:RTX) from Buy to Neutral and lowered the price target from $120 to $95.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:42 am

BA

B of A Securities analyst Ronald Epstein has upgraded Boeing (NYSE:BA) from Neutral to Buy and raised the price target from $225 to $300.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:40 am

META

Wells Fargo analyst Ken Gawrelski has upgraded Meta Platforms (NASDAQ:META) from Equal-Weight to Overweight and raised the price target from $313 to $389.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:39 am

MAG

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on MAG Silver and raises the price target from C$16 to C$20.5.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:17 am

VRCA

HC Wainwright & Co. analyst Oren Livnat maintains a 'Buy' rating on Verrica Pharmaceuticals (NASDAQ:VRCA) and raises the price target from $11 to $12.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:12 am

ALKS

HC Wainwright & Co. analyst Douglas Tsao has reiterated a Neutral rating on Alkermes (NASDAQ:ALKS) and maintained a $34 price target.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:12 am